Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

John Phillip Forman, M.D.

TitleAssistant Professor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressChanning Laboratory
181 Longwood Ave
Boston MA 02115
Phone617/525-3092
Fax617/525-2008

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Li S, Chiuve SE, Flint A, Pai JK, Forman JP, Hu FB, Willett WC, Mukamal KJ, Rimm EB. Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med. 2013 Oct 28; 173(19):1808-19.
    View in: PubMed
  2. Mandel EI, Forman JP, Curhan GC, Taylor EN. Plasma bicarbonate and odds of incident hypertension. Am J Hypertens. 2013 Dec; 26(12):1405-12.
    View in: PubMed
  3. McMullan CJ, Schernhammer ES, Forman JP. Melatonin level and risk for type 2 diabetes--in reply. JAMA. 2013 Aug 7; 310(5):537.
    View in: PubMed
  4. McMullan CJ, Curhan GC, Schernhammer ES, Forman JP. Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women. Am J Epidemiol. 2013 Jul 15; 178(2):231-8.
    View in: PubMed
  5. Gangwisch JE, Feskanich D, Malaspina D, Shen S, Forman JP. Sleep duration and risk for hypertension in women: results from the nurses' health study. Am J Hypertens. 2013 Jul; 26(7):903-11.
    View in: PubMed
  6. McMullan CJ, Schernhammer ES, Rimm EB, Hu FB, Forman JP. Melatonin secretion and the incidence of type 2 diabetes. JAMA. 2013 Apr 3; 309(13):1388-96.
    View in: PubMed
  7. Forman JP, Scott JB, Ng K, Drake BF, Suarez EG, Hayden DL, Bennett GG, Chandler PD, Hollis BW, Emmons KM, Giovannucci EL, Fuchs CS, Chan AT. Effect of vitamin d supplementation on blood pressure in blacks. Hypertension. 2013 Apr; 61(4):779-85.
    View in: PubMed
  8. McMullan CJ, Bakris GL, Phillips RA, Forman JP. Association of BP Variability with Mortality among African Americans with CKD. Clin J Am Soc Nephrol. 2013 May; 8(5):731-8.
    View in: PubMed
  9. Greenberg JO, Vakharia N, Szent-Gyorgyi LE, Desai SP, Turchin A, Forman J, Bonventre JV, Kachalia A. Meaningful measurement: developing a measurement system to improve blood pressure control in patients with chronic kidney disease. J Am Med Inform Assoc. 2013 Jun; 20(e1):e97-e101.
    View in: PubMed
  10. Vaidya A, Underwood PC, Annes JP, Sun B, Williams GH, Forman JP, Williams JS. The influence of sodium- and calcium-regulatory hormone interventions on adipocytokines in obesity and diabetes. Metabolism. 2013 Apr; 62(4):539-47.
    View in: PubMed
  11. Forman JP, Willett WC. Nutrient-wide association studies: another road to the same destination. Circulation. 2012 Nov 20; 126(21):2447-8.
    View in: PubMed
  12. Mozaffarian D, Shi P, Morris JS, Grandjean P, Siscovick DS, Spiegelman D, Willett WC, Rimm EB, Curhan GC, Forman JP. Mercury exposure and risk of hypertension in US men and women in 2 prospective cohorts. Hypertension. 2012 Sep; 60(3):645-52.
    View in: PubMed
  13. Charytan DM, Forman JP. You are what you eat: dietary salt intake and renin-angiotensin blockade in diabetic nephropathy. Kidney Int. 2012 Aug; 82(3):257-9.
    View in: PubMed
  14. Qi Q, Forman JP, Jensen MK, Flint A, Curhan GC, Rimm EB, Hu FB, Qi L. Genetic predisposition to high blood pressure associates with cardiovascular complications among patients with type 2 diabetes: two independent studies. Diabetes. 2012 Nov; 61(11):3026-32.
    View in: PubMed
  15. Cohen L, Curhan GC, Forman JP. Influence of age on the association between lifestyle factors and risk of hypertension. J Am Soc Hypertens. 2012 Jul-Aug; 6(4):284-90.
    View in: PubMed
  16. Mason SM, Wright RJ, Hibert EN, Spiegelman D, Forman JP, Rich-Edwards JW. Intimate partner violence and incidence of hypertension in women. Ann Epidemiol. 2012 Aug; 22(8):562-7.
    View in: PubMed
  17. Forman JP, Scheven L, de Jong PE, Bakker SJ, Curhan GC, Gansevoort RT. Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension. Circulation. 2012 Jun 26; 125(25):3108-16.
    View in: PubMed
  18. Cohen L, Curhan G, Forman J. Association of sweetened beverage intake with incident hypertension. J Gen Intern Med. 2012 Sep; 27(9):1127-34.
    View in: PubMed
  19. Vaidya A, Sun B, Larson C, Forman JP, Williams JS. Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study. J Clin Endocrinol Metab. 2012 Jul; 97(7):2456-65.
    View in: PubMed
  20. Rivas-Tumanyan S, Spiegelman D, Curhan GC, Forman JP, Joshipura KJ. Periodontal disease and incidence of hypertension in the health professionals follow-up study. Am J Hypertens. 2012 Jul; 25(7):770-6.
    View in: PubMed
  21. Vaidya A, Forman JP. Vitamin D and vascular disease: the current and future status of vitamin D therapy in hypertension and kidney disease. Curr Hypertens Rep. 2012 Apr; 14(2):111-9.
    View in: PubMed
  22. Lieu SJ, Curhan GC, Schernhammer ES, Forman JP. Rotating night shift work and disparate hypertension risk in African-Americans. J Hypertens. 2012 Jan; 30(1):61-6.
    View in: PubMed
  23. McMahon GM, Forman JP. Bardoxolone methyl, chronic kidney disease, and type 2 diabetes. N Engl J Med. 2011 Nov 3; 365(18):1746; author reply 1746-7.
    View in: PubMed
  24. Stuebe AM, Schwarz EB, Grewen K, Rich-Edwards JW, Michels KB, Foster EM, Curhan G, Forman J. Duration of lactation and incidence of maternal hypertension: a longitudinal cohort study. Am J Epidemiol. 2011 Nov 15; 174(10):1147-58.
    View in: PubMed
  25. Batool-Anwar S, Malhotra A, Forman J, Winkelman J, Li Y, Gao X. Restless legs syndrome and hypertension in middle-aged women. Hypertension. 2011 Nov; 58(5):791-6.
    View in: PubMed
  26. Vaidya A, Williams JS, Forman JP. The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity (Silver Spring). 2012 Jan; 20(1):186-91.
    View in: PubMed
  27. Mc Causland FR, Niedermaier S, Bijol V, Rennke HG, Choi ME, Forman JP. Lyme disease-associated glomerulonephritis. Nephrol Dial Transplant. 2011 Sep; 26(9):3054-6.
    View in: PubMed
  28. Vaidya A, Sun B, Forman JP, Hopkins PN, Brown NJ, Kolatkar NS, Williams GH, Williams JS. The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians. Clin Endocrinol (Oxf). 2011 Jun; 74(6):783-90.
    View in: PubMed
  29. Tobias DK, Hu FB, Forman JP, Chavarro J, Zhang C. Increased risk of hypertension after gestational diabetes mellitus: findings from a large prospective cohort study. Diabetes Care. 2011 Jul; 34(7):1582-4.
    View in: PubMed
  30. Vaidya A, Forman JP, Underwood PC, Hopkins PN, Williams GH, Pojoga LH, Williams JS. The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men. Eur J Endocrinol. 2011 Jun; 164(6):995-1002.
    View in: PubMed
  31. Vaidya A, Pojoga L, Underwood PC, Forman JP, Hopkins PN, Williams GH, Williams JS. The association of plasma resistin with dietary sodium manipulation, the renin-angiotensin-aldosterone system, and 25-hydroxyvitamin D3 in human hypertension. Clin Endocrinol (Oxf). 2011 Mar; 74(3):294-9.
    View in: PubMed
  32. Zhang L, Curhan GC, Hu FB, Rimm EB, Forman JP. Association between passive and active smoking and incident type 2 diabetes in women. Diabetes Care. 2011 Apr; 34(4):892-7.
    View in: PubMed
  33. Vaidya A, Forman JP, Hopkins PN, Seely EW, Williams JS. 25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians. J Renin Angiotensin Aldosterone Syst. 2011 Sep; 12(3):311-9.
    View in: PubMed
  34. Zhang L, Curhan GC, Forman JP. Plasma insulin-like growth factor-1 level and risk of incident hypertension in nondiabetic women. J Hypertens. 2011 Feb; 29(2):229-35.
    View in: PubMed
  35. Vaidya A, Forman JP, Williams JS. Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension. J Hum Hypertens. 2011 Nov; 25(11):672-8.
    View in: PubMed
  36. Cassidy A, O'Reilly ÉJ, Kay C, Sampson L, Franz M, Forman JP, Curhan G, Rimm EB. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr. 2011 Feb; 93(2):338-47.
    View in: PubMed
  37. Vaidya A, Forman JP. Vitamin D and hypertension: current evidence and future directions. Hypertension. 2010 Nov; 56(5):774-9.
    View in: PubMed
  38. Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD. Primary care management of chronic kidney disease. J Gen Intern Med. 2011 Apr; 26(4):386-92.
    View in: PubMed
  39. Wang L, Manson JE, Forman JP, Gaziano JM, Buring JE, Sesso HD. Dietary fatty acids and the risk of hypertension in middle-aged and older women. Hypertension. 2010 Oct; 56(4):598-604.
    View in: PubMed
  40. Paik JM, Curhan GC, Forman JP, Taylor EN. Determinants of plasma parathyroid hormone levels in young women. Calcif Tissue Int. 2010 Sep; 87(3):211-7.
    View in: PubMed
  41. Zhang L, Curhan GC, Forman JP. Plasma prolactin level and risk of incident hypertension in postmenopausal women. J Hypertens. 2010 Jul; 28(7):1400-5.
    View in: PubMed
  42. Zhang L, Curhan GC, Forman JP. Plasma resistin levels associate with risk for hypertension among nondiabetic women. J Am Soc Nephrol. 2010 Jul; 21(7):1185-91.
    View in: PubMed
  43. Curhan GC, Forman JP. Sugar-sweetened beverages and chronic disease. Kidney Int. 2010 Apr; 77(7):569-70.
    View in: PubMed
  44. Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension. 2010 May; 55(5):1283-8.
    View in: PubMed
  45. Forman JP, Curhan GC, Schernhammer ES. Urinary melatonin and risk of incident hypertension among young women. J Hypertens. 2010 Mar; 28(3):446-51.
    View in: PubMed
  46. Robinson ES, Fisher ND, Forman JP, Curhan GC. Physical activity and albuminuria. Am J Epidemiol. 2010 Mar 1; 171(5):515-21.
    View in: PubMed
  47. Lai TS, Curhan GC, Forman JP. Insulin resistance and risk of incident hypertension among men. J Clin Hypertens (Greenwich). 2009 Sep; 11(9):483-90.
    View in: PubMed
  48. Zhang L, Curhan GC, Forman JP. Diet-dependent net acid load and risk of incident hypertension in United States women. Hypertension. 2009 Oct; 54(4):751-5.
    View in: PubMed
  49. Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA. 2009 Jul 22; 302(4):401-11.
    View in: PubMed
  50. Schopick EL, Fisher ND, Lin J, Forman JP, Curhan GC. Post-menopausal hormone use and albuminuria. Nephrol Dial Transplant. 2009 Dec; 24(12):3739-44.
    View in: PubMed
  51. Zhang L, Curhan GC, Forman JP. Diet Dependent Net Acid Load and Risk of Incident Hypertension in US Women. Hypertension (in press). 2009.
  52. Forman JP, Curhan GC, Schernhammer ES. Urinary Melatonin and Risk of Incident Hypertension among Young Women. J Hypertens (in press). 2009.
  53. Forman JP, Stampfer MJ, Curhan GC. Diet and Lifestyle Risk Factors Associated with Incident Hypertension in Women. JAMA (in press). 2009.
  54. Cooper Worobey C, Fisher ND, Cox D, Forman JP, Curhan GC. Genetic polymorphisms and the risk of accelerated renal function decline in women. PLoS One. 2009; 4(3):e4787.
    View in: PubMed
  55. Forman JP, Choi H, Curhan GC. Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med. 2009 Jan 26; 169(2):155-62.
    View in: PubMed
  56. Forman JP, Choi H, Curhan GC. Fructose and vitamin C intake do not influence risk for developing hypertension. J Am Soc Nephrol. 2009 Apr; 20(4):863-71.
    View in: PubMed
  57. Forman JP, Choi HK, Curhan GC. Fructose and Vitamin C Intake and the Risk of Developing Hypertension: Results from Three Large Prospective Cohorts. J Am Soc Nephrol. 2009; [Epub ahead of print].
  58. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008 Nov; 52(5):828-32.
    View in: PubMed
  59. Forman JP, Fisher ND, Schopick EL, Curhan GC. Urinary Albumin Excretion in the Normal Range and Risk of Incident Hypertension Among Women. J Am Soc Nephrol. 2008; 19(10):1983-8.
  60. Taylor EN, Curhan GC, Forman JP. Parathyroid hormone and the risk of incident hypertension. J Hypertens. 2008 Jul; 26(7):1390-4.
    View in: PubMed
  61. Forman JP, Fisher ND, Schopick EL, Curhan GC. Higher levels of albuminuria within the normal range predict incident hypertension. J Am Soc Nephrol. 2008 Oct; 19(10):1983-8.
    View in: PubMed
  62. Forman JP, Fisher ND, Pollak MR, Cox DG, Tonna S, Curhan GC. Renin-Angiotensin System Polymorphisms and Risk of Hypertension: Influence of Environmental Factors. Journal of Clinical Hypertension. 2008; 10(6):459-66.
  63. Forman JP, Fisher ND, Pollak MR, Cox DG, Tonna S, Curhan GC. Renin-angiotensin system polymorphisms and risk of hypertension: influence of environmental factors. J Clin Hypertens (Greenwich). 2008 Jun; 10(6):459-66.
    View in: PubMed
  64. Gao X, Curhan G, Forman JP, Ascherio A, Choi HK. Vitamin C intake and serum uric acid concentration in men. J Rheumatol. 2008 Sep; 35(9):1853-8.
    View in: PubMed
  65. Rifas-Shiman SL, Forman JP, Lane K, Caspard H, Gillman MW. Diabetes and lipid screening among patients in primary care: a cohort study. BMC Health Serv Res. 2008; 8:25.
    View in: PubMed
  66. Forman JP, Rifas-Shiman SL, Taylor EN, Lane K, Gillman MW. Association between the serum anion gap and blood pressure among patients at Harvard Vanguard Medical Associates. J Hum Hypertens. 2008 Feb; 22(2):122-5.
    View in: PubMed
  67. Charytan D*, Forman JP*, Cutlip DE (*co-first authors). Risk of Target Lesion Revascularization after Coronary Stenting in Patients with and without Chronic Kidney Disease. Nephrology, Dialysis, and Transplantation. 2007; 22(9):2578-85.
  68. Taylor EN, Forman JP, Farwell WR. Serum anion gap and blood pressure in the national health and nutrition examination survey. Hypertension. 2007 Aug; 50(2):320-4.
    View in: PubMed
  69. Charytan D, Forman JP, Cutlip DE. Risk of target lesion revascularization after coronary stenting in patients with and without chronic kidney disease. Nephrol Dial Transplant. 2007 Sep; 22(9):2578-85.
    View in: PubMed
  70. Forman JP, Price DA, Stevanovic R, Fisher ND. Racial differences in renal vascular response to angiotensin blockade with captopril or candesartan. J Hypertens. 2007 Apr; 25(4):877-82.
    View in: PubMed
  71. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007 May; 49(5):1063-9.
    View in: PubMed
  72. Forman JP, Rimm EB, Curhan GC. Frequency of analgesic use and risk of hypertension among men. Arch Intern Med. 2007 Feb 26; 167(4):394-9.
    View in: PubMed
  73. Forman, JP. Controversies in Blood Pressure. Nephrology Rounds. 2007; 5(1).
  74. Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol. 2007 Jan; 18(1):287-92.
    View in: PubMed
  75. Taylor EN, Mount DB, Forman JP, Curhan GC. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors. Am J Kidney Dis. 2006 May; 47(5):780-9.
    View in: PubMed
  76. Taylor EN, Mount DB, Forman JP, Curhan GC. 24-hour Excretion of Calcium, Citrate, and Other Factors and the Risk of Prevalent Hypertension. Am J Kid Dis. 2006; 47(5):780-9.
  77. Forman JP, Brenner BM. 'Hypertension' and 'microalbuminuria': the bell tolls for thee. Kidney Int. 2006 Jan; 69(1):22-8.
    View in: PubMed
  78. Forman JP, Brenner BM. “Hypertension” and “Microalbuminuria”: the Bell Tolls for Thee. Kidney Int. 2006; 69(1):22-8.
  79. Forman JP, Bischoff-Ferrari HA, Willett WC, Stampfer MJ, Curhan GC. Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension. 2005 Oct; 46(4):676-82.
    View in: PubMed
  80. Forman JP, Stampfer MJ, Curhan GC. Non-narcotic analgesic dose and risk of incident hypertension in US women. Hypertension. 2005 Sep; 46(3):500-7.
    View in: PubMed
  81. Humphreys BD, Forman JP, Zandi-Nejad K, Bazari H, Seifter J, Magee CC. Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital. Am J Kidney Dis. 2005 Jul; 46(1):143-6.
    View in: PubMed
  82. Lee KM, Forman JP, McNerney ME, Stepp S, Kuppireddi S, Guzior D, Latchman YE, Sayegh MH, Yagita H, Park CK, Oh SB, Wülfing C, Schatzle J, Mathew PA, Sharpe AH, Kumar V. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions. Blood. 2006 Apr 15; 107(8):3181-8.
    View in: PubMed
  83. Yamada A, Salama AD, Sho M, Najafian N, Ito T, Forman JP, Kewalramani R, Sandner S, Harada H, Clarkson MR, Mandelbrot DA, Sharpe AH, Oshima H, Yagita H, Chalasani G, Lakkis FG, Auchincloss H, Sayegh MH. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. J Immunol. 2005 Feb 1; 174(3):1357-64.
    View in: PubMed
  84. Forman JP, Rimm EB, Stampfer MJ, Curhan GC. Folate intake and the risk of incident hypertension among US women. JAMA. 2005 Jan 19; 293(3):320-9.
    View in: PubMed
  85. Forman JP, Sayegh MH. Renal Transplantation. Levy J, editor. The Year In Renal Medicine. 2005.
  86. Forman JP, Tolkoff-Rubin N, Pascual M, Lin J. Hepatitis C, acute humoral rejection, and renal allograft survival. J Am Soc Nephrol. 2004 Dec; 15(12):3249-55.
    View in: PubMed
  87. Forman JP, Lin J, Pascual M, Denton MD, Tolkoff-Rubin N. Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation. Am J Transplant. 2004 Nov; 4(11):1786-91.
    View in: PubMed
  88. Forman JP. Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy. N Engl J Med. 2004 Feb 19; 350(8):836-8; author reply 836-8.
    View in: PubMed
  89. Forman JP, Singh AK. The Acute Coronary Syndrome in Chronic Kidney Disease. Nephrology Rounds. 2003; (1):1-6.
  90. Chun T, Grandea AG, Lybarger L, Forman J, Van Kaer L, Wang CR. Functional roles of TAP and tapasin in the assembly of M3-N-formylated peptide complexes. J Immunol. 2001 Aug 1; 167(3):1507-14.
    View in: PubMed
  91. Bai A, Aldrich CJ, Forman J. Factors controlling the trafficking and processing of a leader-derived peptide presented by Qa-1. J Immunol. 2000 Dec 15; 165(12):7025-34.
    View in: PubMed
  92. Jia SH, Kurepa Z, Bai A, Forman J. Comparative ability of Qdm/Qa-1b, kb, and Db to protect class Ilow cells from NK-mediated lysis in vivo. J Immunol. 2000 Dec 1; 165(11):6142-7.
    View in: PubMed
  93. Seaman MS, Wang CR, Forman J. MHC class Ib-restricted CTL provide protection against primary and secondary Listeria monocytogenes infection. J Immunol. 2000 Nov 1; 165(9):5192-201.
    View in: PubMed
  94. Haglund K, Forman J, Kräusslich HG, Rose JK. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Virology. 2000 Mar 1; 268(1):112-21.
    View in: PubMed
  95. Fathallah-Shaykh HM, Zhao LJ, Kafrouni AI, Smith GM, Forman J. Gene transfer of IFN-gamma into established brain tumors represses growth by antiangiogenesis. J Immunol. 2000 Jan 1; 164(1):217-22.
    View in: PubMed
  96. Sivakumar PV, Gunturi A, Salcedo M, Schatzle JD, Lai WC, Kurepa Z, Pitcher L, Seaman MS, Lemonnier FA, Bennett M, Forman J, Kumar V. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development. J Immunol. 1999 Jun 15; 162(12):6976-80.
    View in: PubMed
  97. Seaman MS, Pérarnau B, Lindahl KF, Lemonnier FA, Forman J. Response to Listeria monocytogenes in mice lacking MHC class Ia molecules. J Immunol. 1999 May 1; 162(9):5429-36.
    View in: PubMed
  98. Roberts A, Buonocore L, Price R, Forman J, Rose JK. Attenuated vesicular stomatitis viruses as vaccine vectors. J Virol. 1999 May; 73(5):3723-32.
    View in: PubMed
  99. Speiser DE, Bachmann MF, Soloski MJ, Forman J, Ohashi PS. Alloreactive cytotoxic T cells recognize minor transplantation antigens presented by major histocompatibility complex class Ib molecules. Transplantation. 1998 Sep 15; 66(5):646-50.
    View in: PubMed
  100. Roberts A, Kretzschmar E, Perkins AS, Forman J, Price R, Buonocore L, Kawaoka Y, Rose JK. Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J Virol. 1998 Jun; 72(6):4704-11.
    View in: PubMed
  101. Bouwer HG, Bai A, Forman J, Gregory SH, Wing EJ, Barry RA, Hinrichs DJ. Listeria monocytogenes-infected hepatocytes are targets of major histocompatibility complex class Ib-restricted antilisterial cytotoxic T lymphocytes. Infect Immun. 1998 Jun; 66(6):2814-7.
    View in: PubMed
  102. Jiang H, Kashleva H, Xu LX, Forman J, Flaherty L, Pernis B, Braunstein NS, Chess L. T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc Natl Acad Sci U S A. 1998 Apr 14; 95(8):4533-7.
    View in: PubMed
  103. Bouwer HG, Seaman MS, Forman J, Hinrichs DJ. MHC class Ib-restricted cells contribute to antilisterial immunity: evidence for Qa-1b as a key restricting element for Listeria-specific CTLs. J Immunol. 1997 Sep 15; 159(6):2795-801.
    View in: PubMed
  104. DeCloux A, Woods AS, Cotter RJ, Soloski MJ, Forman J. Dominance of a single peptide bound to the class I(B) molecule, Qa-1b. J Immunol. 1997 Mar 1; 158(5):2183-91.
    View in: PubMed
  105. Forman J, Aizer A, Young CR. Myocardial infarction resulting from caffeine overdose in an anorectic woman. Ann Emerg Med. 1997 Jan; 29(1):178-80.
    View in: PubMed
  106. Yu YY, Forman J, Aldrich C, Blazar B, Flaherty L, Kumar V, Bennett M. Natural killer cells recognize common antigenic motifs shared by H-2Dd, H-2Ld and possibly H-2Dr molecules expressed on bone marrow cells. Int Immunol. 1994 Sep; 6(9):1297-306.
    View in: PubMed
  107. Aldrich CJ, Ljunggren HG, Van Kaer L, Ashton-Rickardt PG, Tonegawa S, Forman J. Positive selection of self- and alloreactive CD8+ T cells in Tap-1 mutant mice. Proc Natl Acad Sci U S A. 1994 Jul 5; 91(14):6525-8.
    View in: PubMed
  108. Teitell M, Holcombe H, Cheroutre H, Aldrich CJ, Stroynowski I, Forman J, Kronenberg M. The alpha 3 domain of the Qa-2 molecule is defective for CD8 binding and cytotoxic T lymphocyte activation. J Exp Med. 1993 Dec 1; 178(6):2139-45.
    View in: PubMed
  109. Lowen LC, Aldrich CJ, Forman J. Analysis of T cell receptors specific for recognition of class IB antigens. J Immunol. 1993 Dec 1; 151(11):6155-65.
    View in: PubMed
  110. Aldrich CJ, Hammer RE, Jones-Youngblood S, Koszinowski U, Hood L, Stroynowski I, Forman J. Negative and positive selection of antigen-specific cytotoxic T lymphocytes affected by the alpha 3 domain of MHC I molecules. Nature. 1991 Aug 22; 352(6337):718-21.
    View in: PubMed
  111. Cassell D, Forman J. Two roles for CD4 cells in the control of the generation of cytotoxic T lymphocytes. J Immunol. 1991 Jan 1; 146(1):3-10.
    View in: PubMed
  112. Cassell DJ, Forman J. Regulation of the cytotoxic T lymphocyte response against Qa-1 alloantigens. J Immunol. 1990 Jun 1; 144(11):4075-81.
    View in: PubMed
  113. Schreiber KL, Forman J. Effect of graft-versus-host disease on anti-tumor immunity. J Immunol. 1990 Mar 1; 144(5):2018-26.
    View in: PubMed
  114. Jones-Youngblood SL, Wieties K, Forman J, Hammer RE. Effect of the expression of a hepatocyte-specific MHC molecule in transgenic mice on T cell tolerance. J Immunol. 1990 Feb 15; 144(4):1187-95.
    View in: PubMed
  115. Hedley ML, Drake BL, Head JR, Tucker PW, Forman J. Differential expression of the class I MHC genes in the embryo and placenta during midgestational development in the mouse. J Immunol. 1989 Jun 1; 142(11):4046-53.
    View in: PubMed
  116. Mann DW, Stroynowski I, Hood L, Forman J. An H-2Ld hybrid molecule with a Qa-2 alpha-3 domain and phosphatidyl-inositol anchor is not recognized by H-2Ld-specific cytotoxic T lymphocytes. J Immunol. 1989 Jan 1; 142(1):318-22.
    View in: PubMed
  117. Taurog JD, Lowen L, Forman J, Hammer RE. HLA-B27 in inbred and non-inbred transgenic mice. Cell surface expression and recognition as an alloantigen in the absence of human beta 2-microglobulin. J Immunol. 1988 Dec 1; 141(11):4020-3.
    View in: PubMed
  118. Mann D, Forman J. Recognition by cytotoxic T lymphocytes of Qa-2 antigens. Sensitivity of Qa-2 molecules to phosphatidylinositol-specific phospholipase C. J Immunol. 1988 Sep 15; 141(6):1813-8.
    View in: PubMed
  119. Mann DW, McLaughlin-Taylor E, Wallace RB, Forman J. An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes. J Exp Med. 1988 Jul 1; 168(1):307-24.
    View in: PubMed
  120. Leo O, Foo M, Forman J, Shivakumar S, Rabinowitz R, Bluestone JA. Selective expression of the Ly-6C.2 epitope on Lyt-2+ T cells that can develop in the absence of thymic influence. J Immunol. 1988 Jul 1; 141(1):37-44.
    View in: PubMed
  121. Koeller D, Lieberman R, Miyazaki J, Appella E, Ozato K, Mann DW, Forman J. Introduction of H-2Dd determinants into the H-2Ld antigen by site-directed mutagenesis. J Exp Med. 1987 Sep 1; 166(3):744-60.
    View in: PubMed
  122. McCluskey J, Boyd L, Foo M, Forman J, Margulies DH, Bluestone JA. Analysis of hybrid H-2D and L antigens with reciprocally mismatched aminoterminal domains: functional T cell recognition requires preservation of fine structural determinants. J Immunol. 1986 Dec 15; 137(12):3881-90.
    View in: PubMed
  123. Stroynowski I, Clark S, Henderson LA, Hood L, McMillan M, Forman J. Interaction of alpha 1 with alpha 2 region in class I MHC proteins contributes determinants recognized by antibodies and cytotoxic T cells. J Immunol. 1985 Sep; 135(3):2160-6.
    View in: PubMed
  124. Stroynowski I, Forman J, Goodenow RS, Schiffer SG, McMillan M, Sharrow SO, Sachs DH, Hood L. Expression and T cell recognition of hybrid antigens with amino-terminal domains encoded by Qa-2 region of major histocompatibility complex and carboxyl termini of transplantation antigens. J Exp Med. 1985 May 1; 161(5):935-52.
    View in: PubMed
  125. Forman J, Ciavarra R, Henderson LA. Recognition of an Igh-linked histocompatibility antigen, H-40, on B-cell tumors by cytotoxic T lymphocytes. Surv Immunol Res. 1985; 4(1):41-7.
    View in: PubMed
  126. Henderson LA, Ciavarra R, Riblet R, Forman J. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals. J Immunol. 1984 Nov; 133(5):2778-85.
    View in: PubMed
  127. Forman J, Goodenow RS, Hood L, Ciavarra R. Use of DNA-mediated gene transfer to analyze the role of H-2Ld in controlling the specificity of anti-vesicular stomatitis virus cytotoxic T cells. J Exp Med. 1983 Apr 1; 157(4):1261-72.
    View in: PubMed
  128. Forman J, Ciavarra R, Vitetta ES. Cytotoxic T cells specific for antigens expressed on surface immunoglobulin-positive cells. J Exp Med. 1981 Nov 1; 154(5):1357-68.
    View in: PubMed
  129. Streilein JW, Forman J. Are allogeneic and associative recognition coincident T cell paradigms? Transplantation. 1981 Mar; 31(3):183-6.
    View in: PubMed
  130. Black PL, Vitetta ES, Forman J, Kang CY, May RD, Uhr JW. Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells. Eur J Immunol. 1981 Jan; 11(1):48-55.
    View in: PubMed
  131. Ciavarra RP, Kang CY, Forman J. Vesicular stomatitis antigens recognized by cytotoxic cells: analysis with defective interfering particles and reconstituted membrane vesicles. J Immunol. 1980 Jul; 125(1):336-43.
    View in: PubMed
  132. Forman J. H-2 unrestricted cytotoxic T cell activity against antigens controlled by genes in the QA/TLA region. J Immunol. 1979 Dec; 123(6):2451-5.
    View in: PubMed
  133. Forman J, Vitetta ES. Relationship between trinitrophenol and H-2 antigens on trinitrophenyl-modified spleen cells. IV. Correlation between the loss of cell surface trinitrophenyl-H-2 molecules and functional activity of derivatized cells in an anti-TNP-CML assay. J Immunol. 1978 Sep; 121(3):1002-6.
    View in: PubMed
  134. Forman J. T cell-mediated cytotoxicity against trinitrophenyl-modified cells: effect of glutaraldehyde treatment on the immunogenicity and antigenicity of trinitrophenyl-modified cells. J Immunol. 1977 May; 118(5):1755-62.
    View in: PubMed
  135. Forman J, Klein J. Immunogeneic analysis of H-2 mutations. II. Cellular immunity to the H-2DA mutation. J Immunol. 1975 Sep; 115(3):711-5.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Forman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_